C12Y 204/02012
Nicotinamide phosphoribosyltransferase , i.e. visfatin
Official title: Nicotinamide phosphoribosyltransferase (2.4.2.12), i.e. visfatin
C12Y204/02012 (Nicotinamide phosphoribosyltransferase , i.e. visfatin) appears on 15 US grants and 47 published applications in this corpus.
Search patents in C12Y- Granted patents
- 15
- Published applications
- 47
- Assignees
- 32
- Inventors
- 81
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 3 |
| 2016 | 2 | 2 |
| 2017 | 1 | 2 |
| 2018 | 1 | 5 |
| 2019 | 2 | 4 |
| 2020 | 1 | 3 |
| 2021 | 1 | 3 |
| 2022 | 2 | 4 |
| 2023 | 1 | 5 |
| 2024 | 2 | 4 |
| 2025 | 1 | 3 |
| 2026 | 1 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bottom-up assembly of synthetic extracellular vesicles10 Mar 2026US 12,569,439 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Innovative method for improving enzyme activity of NMN biosynthetic enzyme nampt28 Jan 2025US 12,209,244 B2Hoboomlife Bio-Technology (Shenzhen) Co., Ltd.
- Genetically engineered bacteria, its construction method and its application in producing NAD+ method24 Dec 2024US 12,173,338 B2Hefei Knature Bio-Pharm Co., Ltd.
- Method for producing nicotinamide mononucleotide16 Apr 2024US 11,959,116 B2Asahi Kasei Pharma Corporation
- Biomarkers and methods of use for radiation-induced lung injury22 Aug 2023US 11,733,242 B2Arizona Board of Regents on Behalf of the University of Arizona
- Production and use of extracellular vesicle-contained enampt10 Sep 2026US 2026/0263365 A1Washington University
- Nicotinamide adenine dinucleotide devices and compositions and methods for making the same27 Aug 2026US 2026/0250695 A1Bio Capital Holdings, LLC
- Protein devices and compositions and methods for making the same30 Jul 2026US 2026/0218214 A1Bio Capital Holdings, LLC
- Peptide composition having angiogenic activity, and pharmaceutical composition using same and cosmetic composition using same18 Jun 2026US 2026/0166130 A1Labtomedi Cro Co.,Ltd.
- Methods and compositions for cancer therapy12 Mar 2026US 2026/0069581 A1
Most cited
By later US patents
- Targeting NAD+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity4US 10,603,334 B2Newsouth Innovation Pty Limited · 2020
- Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method4US 9,322,024 B2Korea University Research and Business Foundation · 2016
- NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation3US 9,877,981 B2NewSouth Innovations Pty Limited · 2018